We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Santarus Ulcerative Colitis Drug to Hit Shelves in March
The item has been added to your shopping cart.
Santarus Ulcerative Colitis Drug to Hit Shelves in March
January 18, 2013
The FDA has approved Santarus’ daily extended-release drug Uceris to induce remission of mild to moderate active ulcerative colitis, a form of inflammatory bowel disease.